Filing summary
Entity and period: The supplied filing is for PN Med Group Inc., not Chronoscale Holdings Corp. It is an unaudited Form 10-Q for the quarter ended September 30, 2013, covering the three and six months ended that date. The company has a March 31 fiscal year-end, so the six-month figures cover April–September 2013. The filing describes PN Med as a development-stage company and checks “shell company.” Financial amounts are in U.S. dollars.
Financial performance and condition
| Metric | Three months ended Sept. 30 | Six months ended Sept. 30 |
|---|---|---|
| Revenue, 2013 and 2012 | $0 in both periods | $0 in both periods |
| Operating expenses, 2013 | $1,493 | $24,687 |
| Net loss, 2013 | $1,493 | $24,687 |
| Net loss, 2012 | $1,252 | $6,147 |
| Loss per share, 2013 and 2012 | $(0.00) in both periods | $(0.00) in both periods |
- Six-month 2013 operating expenses were primarily professional fees of $24,559; the comparable 2012 amount was $6,021. Three-month professional fees were $1,433 in 2013 and $1,175 in 2012. No profit or meaningful margin was reported because the company had no revenue.
- At September 30, 2013, cash and total assets were $438, down from $29,175 at March 31, 2013. Current liabilities were $10,074, comprising $750 accrued expenses and a $9,324 shareholder loan. The loan is unsecured, non-interest-bearing, and due on demand. The filing reports stockholders’ deficit of $9,636, versus equity of $15,051 at March 31.
- Six-month net cash used in operating activities was $28,737, versus $9,897 in the prior-year period. Investing cash flow was zero; financing cash flow was zero in 2013 versus $14,181 provided in 2012. Cash declined from $29,175 to $438 during the six months.
- The filing reports no bank financing or credit lines. No interest or income taxes were paid in the periods shown. Debt beyond the shareholder loan is not reported.
Changes, outlook, and risks
- The six-month net loss increased to $24,687 from $6,147, while quarterly net loss rose to $1,493 from $1,252. The company continued to report no revenue.
- PN Med discontinued its planned Chilean medical-supplies distribution business after not commencing operations beyond establishing a website. Management was seeking a new business opportunity, potentially through a merger or acquisition.
- Management said existing working capital and further advances or debt were expected to fund the current level of operations for three months, but also said additional funding would be needed within 12 months. It had no specific funding plan or arrangements in place; prospective financing may be unavailable or dilutive, and new securities could have senior rights.
- The filing identifies substantial doubt about the company’s ability to continue as a going concern. It had limited working capital, no revenue, and expected to depend on additional investment capital. Management gave no assurance that funding, a new business opportunity, or continued viability would be achieved.
- Disclosure controls and procedures were deemed ineffective as of September 30, 2013. Management reported no material change in internal control over financial reporting during the six months. The company reported no known pending or threatened legal proceedings and no material subsequent events.
Important facts to verify
- Confirm the issuer identity: the source filing names PN Med Group Inc., whereas the request metadata names Chronoscale Holdings Corp.
- Check the reported $9,636 stockholders’ deficit against the MD&A, which appears to call that amount “stockholders’ equity” despite the balance sheet showing a deficit.
- Verify the period labeling and six-month comparisons against the filed statements; the report’s title and period references are not consistently presented in the extracted text.
- Assess the company’s near-term liquidity, the demand repayment terms of the shareholder loan, and whether any financing or business transaction was secured after the reporting date.
- Consider the shell-company status, ineffective disclosure controls, going-concern uncertainty, and the absence of revenue when evaluating the filing.